Pet Food Uniform Regulatory Reform Act of 2025 or the PURR Act of 2025This bill establishes the Food and Drug Administration's Center for Veterinary Medicine (CVM) as the sole regulatory authority over pet food for dogs and cats. It also provides certain flexibilities for pet food manufacturers with respect to the types of ingredients they may use and the associated labeling and marketing requirements.The bill specifies that, with exceptions for certain existing oversight activities, no state or local government may establish, implement, or enforce any authority or requirement relating to pet food marketing or labeling and instead provides for oversight by the CVM.The bill requires the CVM to review and act on pet food ingredient submissions within 90 days. Additionally, the bill provides a presumption that pet food ingredients are generally recognized as safe (GRAS) if they are recognized as acceptable per the Association of American Feed Control Officials and the CVM does not find otherwise. Manufacturers may voluntarily notify the CVM of ingredients that are considered GRAS but that have not yet been specifically recognized as such.The bill also allows manufacturers to state, without prior approval, that their products (1) sometimes, but not always, have certain ingredients (e.g., flavors); (2) have certain health benefits (e.g., tartar control); or (3) are human grade or natural, if certain conditions are met.  

Protect Funding for Women's Health Care Act This bill prohibits federal funding of Planned Parenthood Federation of America or its affiliates, subsidiaries, successors, or clinics.

Family and Small Business Taxpayer Protection Act This bill rescinds unobligated funds that were provided by the Inflation Reduction Act of 2022 to the Internal Revenue Service (IRS) for enforcement activities related to the determination and collection of taxes, for operations support for taxpayer services and enforcement activities, and for a task force to research options for a free, direct electronic filing (e-filing) tax return system. The bill also rescinds unobligated funds that were provided by the Inflation Reduction Act of 2022 for expenses of theTreasury Inspector General for Tax Administration,Office of Tax Policy,U.S. Tax Court, andoffices within the Department of the Treasury that provide oversight and support for the IRS.  

RIFLE Act of 2025 Reining In Federal Licensing Enforcement Act of 2025

Promoting Domestic Energy Production Act

Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025

Main Street Tax Certainty Act

Life at Conception Act

Protect American Election Administration Act of 2025